公司資料

Immix Biopharma 股價、新聞與催化劑

股票代碼:: IMMX
交易所:: NASDAQ
產業:: Biopharma
所在地:: United States

股票表現

11.34 USD (+3.37%)

收盤價

最後更新: 2026年8月17日

596M USD

市值

股價為何變動

As of Aug 17, 2026, IMMX closed up 3.37% at $11.34. No new same-company headline was identified in the current news window.

公司概覽

業務概覽

Immix Biopharma is a biotechnology company focused on immune-driven therapies and oncology programs. Its strategy centers on translating immune biology into targeted treatment options.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ, Immix sits in specialty biotechnology.

商業模式特徵

The company depends on clinical data, platform validation, and the ability to build a differentiated cancer story.

生技產業定位

Immix is a catalyst-sensitive biotech name whose stock depends on early clinical progress.

未來催化劑

Immix’s catalysts are the oncology and immunology pipeline, especially any update that shows the company can still generate a clearer clinical path. The story remains early and data-dependent.